Houston Clinical Trials is a clinical research center located in the heart of Houston, Texas. This community of health care professionals provides access to investigational medications to persons suffering from mental illness. Our President and Medical Director, Alain Katic, M.D., is a board certified psychiatrist who has completed over 350 Phase I-IV clinical trials in adult, adolescent and child psychiatry. As a principal investigator, Dr. Katic has conducted clinical trials for a comprehensive spectrum of indications including Attention Deficit/Hyperactivity Disorder (ADHD), Major depressive disorder (MDD), bipolar disorder, anxiety disorder, schizophrenia, sleep disorders, and substance abuse.
Since 2011, Dr. Katic and the Houston Clinical Trials team have conducted clinical trials of new & innovative treatments for such illnesses as Attention Deficit Hyperactivity Disorder (ADHD), Schizophrenia, Bipolar Disorder, Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).
Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical to the advancement of medicine and making available new and helpful medications. It is our mission at Houston Clinical Trials to play an integral role in the advancement process.